EX-10.17



 Exhibit 10.17 
 ***Text Omitted and Filed Separately 
 with the Securities and Exchange
Commission. 
 Confidential Treatment Requested 
 Under 17 C.F.R. Sections 200.80(b)(4) 
 and 230.406. 

											
	 




 DPT Laboratories, Ltd.
 318 McCullough
 San Antonio, TX 78215

Tel: (210) 476-8150
	  	  
 April 9, 2012

 
 Ashok Chavan, Ph.D.
 Insys Therapeutics, Inc.
 10220 South 51st Street,

Suite 2
 Phoenix, AZ 85044

 
 Re:  Contract Manufacturing
Agreement dated May 24, 2011 between INSYS

         THERAPEUTICS, INC. and DPT LABORATORIES, LTD.
(“Manufacturing

         Agreement”)

 
 Dear Ashok:

 
 This letter is to confirm our mutual agreement to amend the
prices of the above-captioned Agreement from January 1, 2012 through December 31, 2012. We have agreed that the prices shall be revised as set forth in Schedule A attached hereto.

 
 All other terms and conditions contained in the said Agreement
thereto shall remain in full force and effect.
  
 If
this meets with your understanding and agreement, please sign and date below, retaining an original and returning the other original to my attention by April 20, 2012.
  

		  		  		  		  	Yours truly,
		  		  		  		  		  	
		  	 ACCEPTED AND AGREED TO
 THIS 23rd DAY OF APRIL, 2012
	  		  	DPT LAKEWOOD, LLC
						
		  	By:	  	 /s/ Michael Babich
	  		  	By:	  	 /s/ Paul Josephs

		  	Print Name:	  	 Michael Babich
	  		  		  	Paul Josephs
		  	Title:	  	 CEO
	  		  		  	Vice President of Sales &
		  		  		  		  		  	 Marketing

		  	 Page 1 of 3
 Confidential










			
	Schedule A - 2012 - Revision #2 - March 30, 2012	 	





 Client -             #713 INSYS Therapeutics, Inc.

  

																											
	 PRODUCT
 CODE
	 	 PRODUCT DESCRIPTION
	 	ANNUAL
QUANTITY
(Spray
Devices)	 	ORDER
QUANTITY
(Batch Size)
(Spray
Devices)	 	Batch
Size	 	# of
BATCHES
per ORDER	 	# of
BATCHES
per YEAR	 	MANUFACTURING
PRICE per spray
device($)	 	MATERIAL
PRICE per
spray device
($)	 	TOTAL
PRICE
per spray
device
US $	 	MANUFACTURING
PRICE per carton($)	 	MATERIAL
PRICE per
carton($)	 	TOTAL
PRICE
per carton
US $
	 	 
	 [...***...]
	 	SUBSYS®(fentanyl sublingual spray) [...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	$[...***...]	 	[...***...]	 	[...***...]	 	$[...***...]	 	[...***...]	 	[...***...]	 	
	 [...***...]
	 	SUBSYS®(fentanyl sublingual spray) [...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	$[...***...]	 	[...***...]	 	[...***...]	 	$[...***...]	 	[...***...]	 	[...***...]	 	
		 		 		 		 		 		 		 		 		 		 		 		 		 	
	 [...***...]
	 	SUBSYS®(fentanyl sublingual spray) [...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	$[...***...]	 	[...***...]	 	[...***...]	 	$[...***...]	 	[...***...]	 	[...***...]	 	
	 [...***...]
	 	SUBSYS®(fentanyl sublingual spray) [...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	$[...***...]	 	[...***...]	 	[...***...]	 	$[...***...]	 	[...***...]	 	[...***...]	 	
	 [...***...]
	 	SUBSYS®(fentanyl sublingual spray) [...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	$[...***...]	 	[...***...]	 	[...***...]	 	$[...***...]	 	[...***...]	 	[...***...]	 	
	 [...***...]
	 	SUBSYS®(fentanyl sublingual spray) [...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	$[...***...]	 	[...***...]	 	[...***...]	 	$[...***...]	 	[...***...]	 	[...***...]	 	
	 [...***...]
	 	SUBSYS®(fentanyl sublingual spray) [...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	[...***...]	 	$[...***...]	 	[...***...]	 	[...***...]	 	$[...***...]	 	[...***...]	 	[...***...]	 	

 Notes: 
  

	1)	Manufacturing and Materials Fee’s are based on [...***...]. 


	2)	Pricing to be effective: [...***...] through [...***...]. 


	 	Any and all products to be delivered on or after [...***...] will be subject to new pricing. 


	3)	Client orders are based [...***...]. 


	4)	The Material Fee is [...***...]. THE API is supplied by the INSYS Therapeutics. 


	5)	Material Handling Fee is [...***...]% [...***...]. 


	6)	Pricing is [...***...]. 

  

	
	 Page 2 of 3
 Confidential
 ©Copyright 2010 DPT Laboratories, Ltd All rights reserved


 ***Confidential Treatment Requested 








			
	Schedule A - 2012 - Revision #2 - March 30, 2012	 	





 Client -             #713 INSYS Therapeutics, Inc.

  

	7)	[...***...]. 


	8)	The original Schedule A dated June 1, 2011 [...***...]. 


	9)	[...***...]. 


	10)	 The launch of
SUBSYS® products will be March 2012. 



	11)	[...***...]. 


	12)	[...***...]. 

  

									
	INSYS Therapeutics, Inc.	 		 	DPT Lakewood, LLC
					
	By:	 	/s/ Michael Babich	 		 	By:	 	/s/ Paul Josephs
	Print Name:	 	Michael Babich	 		 	Print Name:	 	Paul Josephs
	Title:	 	CEO	 		 	Title:	 	VP Sales & Mktg
	Date:	 	4/23/12	 		 	Date:	 	4/9/12

  
  

					
		 	 Page 3 of 3
 Confidential
 ©Copyright 2010 DPT Laboratories, Ltd All rights reserved
	 	

 ***Confidential Treatment Requested